Back to Search
Start Over
APOBEC3 upregulation drives gemcitabine resistance.
- Source :
-
Nature cancer [Nat Cancer] 2024 Jun; Vol. 5 (6), pp. 818-820. - Publication Year :
- 2024
- Subjects :
- Humans
Antimetabolites, Antineoplastic pharmacology
Antimetabolites, Antineoplastic therapeutic use
APOBEC Deaminases genetics
APOBEC Deaminases metabolism
Gene Expression Regulation, Neoplastic drug effects
Cell Line, Tumor
Gemcitabine
Deoxycytidine analogs & derivatives
Deoxycytidine pharmacology
Deoxycytidine therapeutic use
Drug Resistance, Neoplasm genetics
Cytidine Deaminase genetics
Cytidine Deaminase metabolism
Up-Regulation drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 2662-1347
- Volume :
- 5
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Nature cancer
- Publication Type :
- Academic Journal
- Accession number :
- 38778178
- Full Text :
- https://doi.org/10.1038/s43018-024-00755-8